Stratification of the risk of ovarian dysfunction by studying the complexity of intermediate and premutation alleles of the FMR1 gene.

FMR1 FMR1 allelic complexity score diminished ovarian reserve gray zone expansion premature ovarian insufficiency premutation

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
21 Nov 2023
Historique:
revised: 08 11 2023
received: 28 07 2023
accepted: 10 11 2023
medline: 21 11 2023
pubmed: 21 11 2023
entrez: 21 11 2023
Statut: aheadofprint

Résumé

FMR1 premutation female carriers are at risk of developing premature/primary ovarian insufficiency (POI) with an incomplete penetrance. In this study, we determined the CGG repeat size among 1095 women with diminished ovarian reserve (DOR) / POI and characterized the CGG/AGG substructure in 44 women carrying an abnormal FMR1 repeat expansion number, compared to a group of 25 pregnant women carrying an abnormal FMR1 CGG repeat size. Allelic complexity scores of the FMR1 gene were calculated and compared between the two groups. In the DOR/POI cohort, 2.1% of women presented with an intermediate repeat size and 1.9% with a premutation. Our results suggest that the risk of POI is highest in the mid-range of CGG repeats. We observed that the allelic score is significantly higher in POI women compared to the pregnant women group (p-value = 0.02). We suggest that a high allelic score due to more than 2 AGG interspersions in the context of an intermediate number of repetitions could favor POI. Larger studies are still needed to evaluate the relevance of this new tool for the determination of the individual risk of developing POI in women with abnormal number of CGG repeats.

Identifiants

pubmed: 37987117
doi: 10.1002/ajmg.a.63479
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Allen, E. G., Glicksman, A., Tortora, N., Charen, K., He, W., Amin, A., Hipp, H., Shubeck, L., Nolin, S. L., & Sherman, S. L. (2018). FXPOI: Pattern of AGG interruptions does not show an association with age at amenorrhea among women with a premutation. Frontiers in Genetics, 3(9), 292. https://doi.org/10.3389/fgene.2018.00292
Bachelot, A., Rouxel, A., Massin, N., Dulon, J., Courtillot, C., Matuchansky, C., Badachi, Y., Fortin, A., Paniel, B., Lecuru, F., Lefrère-Belda, M.-A., Constancis, E., Thibault, E., Meduri, G., Guiochon-Mantel, A., Misrahi, M., Kuttenn, F., & Touraine, P. (2009). Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure. European Journal of Endocrinology, 161(1), 179-187. https://doi.org/10.1530/EJE-09-0231
Barasoain, M., Barrenetxea, G., Huerta, I., Télez, M., Carrillo, A., Pérez, C., Criado, B., & Arrieta, I. (2013). Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country. Gene, 521(1), 145-149. https://doi.org/10.1016/j.gene.2013.03.032
Bennett, C. E., Conway, G. S., Macpherson, J. N., Jacobs, P. A., & Murray, A. (2010). Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Human Reproduction (Oxford, England), 25(5), 1335-1338. https://doi.org/10.1093/humrep/deq058
Berman, R. F., Buijsen, R. A., Usdin, K., Pintado, E., Kooy, F., Pretto, D., Pessah, I. N., Nelson, D. L., Zalewski, Z., Charlet-Bergeurand, N., Willemsen, R., & Hukema, R. K. (2014). Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome. Journal of Neurodevelopmental Disorders, 6(1), 25. https://doi.org/10.1186/1866-1955-6-25
Biancalana, V., Glaeser, D., McQuaid, S., & Steinbach, P. (2015). EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. European Journal of Human Genetics, 23(4), 417-425. https://doi.org/10.1038/ejhg.2014.185
Boustanai, I., Raanani, H., Aizer, A., Orvieto, R., & Elizur, S. E. (2022). Granulosa cell dysfunction is associated with diminished ovarian response in FMR1 premutation carriers. The Journal of Clinical Endocrinology and Metabolism, 107(11), 3000-3009. https://doi.org/10.1210/clinem/dgac536
Bretherick, K. L., Fluker, M. R., & Robinson, W. P. (2005). FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Human Genetics, 117(4), 376-382. https://doi.org/10.1007/s00439-005-1326-8
Chon, S. J., Umair, Z., & Yoon, M.-S. (2021). Premature ovarian insufficiency : Past, present, and future. Frontiers in Cell and Developmental Biology, 9, 672890. https://doi.org/10.3389/fcell.2021.672890
Cohen, J., Chabbert-Buffet, N., & Darai, E. (2015). Diminished ovarian reserve, premature ovarian failure, poor ovarian responder-a plea for universal definitions. Journal of Assisted Reproduction and Genetics, 32(12), 1709-1712. https://doi.org/10.1007/s10815-015-0595-y
Conway, G. S., Payne, N. N., Webb, J., Murray, A., & Jacobs, P. A. (1998). Fragile X premutation screening in women with premature ovarian failure. Human Reproduction (Oxford, England), 13(5), 1184-1187. https://doi.org/10.1093/humrep/13.5.1184
Devine, K., Mumford, S. L., Wu, M., DeCherney, A. H., Hill, M. J., & Propst, A. (2015). Diminished ovarian reserve in the United States assisted reproductive technology population: Diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertility and Sterility, 104(3), 612-619.e3. https://doi.org/10.1016/j.fertnstert.2015.05.017
Eichler, E. E., Holden, J. J. A., Popovich, B. W., Reiss, A. L., Snow, K., Thibodeau, S. N., Richards, C. S., Ward, P. A., & Nelson, D. L. (1994). Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nature Genetics, 8(1), 88-94. https://doi.org/10.1038/ng0994-88
Ennis, S., Ward, D., & Murray, A. (2006). Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. European Journal of Human Genetics, 14(2), 253-255. https://doi.org/10.1038/sj.ejhg.5201510
Friedman-Gohas, M., Elizur, S. E., Dratviman-Storobinsky, O., Aizer, A., Haas, J., Raanani, H., Orvieto, R., & Cohen, Y. (2020). FMRpolyG accumulates in FMR1 premutation granulosa cells. Journal of Ovarian Research, 13(1), 22. https://doi.org/10.1186/s13048-020-00623-w
Friedman-Gohas, M., Kirshenbaum, M., Michaeli, A., Domniz, N., Elizur, S., Raanani, H., Orvieto, R., & Cohen, Y. (2020). Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers? Journal of Assisted Reproduction and Genetics, 37(4), 849-854. https://doi.org/10.1007/s10815-020-01701-0
Gersak, K., Meden-Vrtovec, H., & Peterlin, B. (2003). Fragile X premutation in women with sporadic premature ovarian failure in Slovenia. Human Reproduction (Oxford, England), 18(8), 1637-1640. https://doi.org/10.1093/humrep/deg327
Gleicher, N. N., Weghofer, A., & Barad, D. H. (2012). Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response. Human Reproduction (Oxford, England), 27(7), 2241-2242; author reply 2242-2243. https://doi.org/10.1093/humrep/des161
Guo, T., Qin, Y., Jiao, X., Li, G., Simpson, J. L., & Chen, Z.-J. (2014). FMR1 premutation is an uncommon explanation for premature ovarian failure in Han Chinese. PLoS One, 9(7), e103316. https://doi.org/10.1371/journal.pone.0103316
Ishizuka, B., Okamoto, N., Hamada, N., Sugishita, Y., Saito, J., Takahashi, N., Ogata, T., & Itoh, M. T. (2011). Number of CGG repeats in the FMR1 gene of Japanese patients with primary ovarian insufficiency. Fertility and Sterility, 96(5), 1170-1174. https://doi.org/10.1016/j.fertnstert.2011.08.028
Komaravalli, P. L., Rani, S. V., Dalal, A., & Jahan, P. (2020). Association analysis of FMR1 genetic variants and primary ovarian insufficiency in south Indian women with a novel approach of CGG repeats classification. European Journal of Medical Genetics, 63(12), 104081. https://doi.org/10.1016/j.ejmg.2020.104081
Lekovich, J., Man, L., Xu, K., Canon, C., Lilienthal, D., Stewart, J. D., Pereira, N., Rosenwaks, Z., & Gerhardt, J. (2018). CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve. Genetics in Medicine, 20(9), 957-964. https://doi.org/10.1038/gim.2017.220
Lu, C.-L., Li, R., Chen, X.-N., Xu, Y.-Y., Yan, L.-Y., Yan, J., Zhang, Y.-Y., Jin, H.-Y., Zhang, W.-X., Qiao, J., & Zhen, X.-M. (2017). The « normal » range of FMR1 triple CGG repeats may be associated with primary ovarian insufficiency in China. Reproductive Biomedicine Online, 34(2), 175-180. https://doi.org/10.1016/j.rbmo.2016.11.001
Mailick, M. R., Hong, J., Greenberg, J., Smith, L., & Sherman, S. (2014). Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 165(8), 705-711. https://doi.org/10.1002/ajmg.b.32277
Napierala, M., Michalowski, D., de Mezer, M., & Krzyzosiak, W. J. (2005). Facile FMR1 mRNA structure regulation by interruptions in CGG repeats. Nucleic Acids Research, 33(2), 451-463. https://doi.org/10.1093/nar/gki186
Ramos, C., Ocampos, M., Barbato, I. T., Niehues, V. M. S., Bicalho, M. D. G., & Nisihara, R. (2022). Association between mutations in the FMR1 gene and ovarian dysfunction in Brazilian patients. JBRA Assisted Reproduction, 26(2), 237-240. https://doi.org/10.5935/1518-0557.20210063
Rodrigues, B., Vale-Fernandes, E., Maia, N., Santos, F., Marques, I., Santos, R., Nogueira, A. J. A., & Jorge, P. (2020). Development and validation of a mathematical model to predict the complexity of FMR1 allele combinations. Frontiers in Genetics, 11, 557147. https://doi.org/10.3389/fgene.2020.557147
Seltzer, M. M., Baker, M. W., Hong, J., Maenner, M., Greenberg, J., & Mandel, D. (2012). Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Psychiatric Genetics, 159B(5), 589-597. https://doi.org/10.1002/ajmg.b.32065
Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005). Fragile X syndrome: Diagnostic and carrier testing. Genetics in Medicine, 7(8), 584-587. https://doi.org/10.1097/01.GIM.0000182468.22666.dd
Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics, 97(3), 189-194. https://doi.org/10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J
Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J., Yadav-Shah, M., & Sherman, S. L. (2005). Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction, 20(2), 402-412. https://doi.org/10.1093/humrep/deh635
Sullivan, S. D., Welt, C., & Sherman, S. (2011). FMR1 and the continuum of primary ovarian insufficiency. Seminars in Reproductive Medicine, 29(4), 299-307. https://doi.org/10.1055/s-0031-1280915
Wang, Q., Barad, D. H., Darmon, S. K., Kushnir, V. A., Wu, Y. G., Lazzaroni-Tealdi, E., Zhang, L., Albertini, D. F., & Gleicher, N. (2018). Reduced RNA expression of the FMR1 gene in women with low (CGGn<26) repeats. PLoS One, 13(12), e0209309. https://doi.org/10.1371/journal.pone.0209309
Wittenberger, M. D., Hagerman, R. J., Sherman, S. L., McConkie-Rosell, A., Welt, C. K., Rebar, R. W., Corrigan, E. C., Simpson, J. L., & Nelson, L. M. (2007). The FMR1 premutation and reproduction. Fertility and Sterility, 87(3), 456-465. https://doi.org/10.1016/j.fertnstert.2006.09.004

Auteurs

Juliette Quilichini (J)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.

Sandrine Perol (S)

Unité de gynécologie médicale, APHP. Centre Université Paris Cité, Hôpital Cochin Port-Royal, Paris, France.

Laurence Cuisset (L)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.

Sarah Grotto (S)

Maternité Port-Royal, APHP. Centre Université Paris Cité, Hôpital Cochin, Paris, France.

Corinne Fouveaut (C)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.

Jean Claude Barbot (JC)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.

Camille Verebi (C)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.

Pénélope Jordan (P)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.

Delphine Héron (D)

Département de Génétique, APHP. Sorbonne Université, Hôpital La Pitié-Salpêtrière, Paris, France.

Denise Molina-Gomes (D)

Service de Biologie de la reproduction, Cytogénétique et Génétique Médicale, CHI Poissy-Saint Germain, Poissy, France.

Eva Pipiras (E)

Unité fonctionnelle de Médecine génomique et génétique clinique, APHP. Université Sorbonne Paris Nord, Hôpital Jean Verdier, Bondy, France.

Michael Grynberg (M)

Gynécologie médicale et médecine de la reproduction, Hôpital Jean Verdier, Bondy, France.

Sophie Catteau-Jonard (S)

Université de Lille, CHU de Lille, Service de Gynécologie Médicale, Lille, France.

Philippe Touraine (P)

Département d'Endocrinologie et médecine de la reproduction, APHP. Sorbonne Université, Pitié-Salpêtrière Hospital, Center for Rare Endocrine and Gynecological Disorders, Paris, France.

Sophie Christin-Maître (S)

Service d'endocrinologie, diabétologie et médecine de la reproduction, APHP. Sorbonne Université, Paris, France.

Geneviève Plu-Bureau (G)

Unité de gynécologie médicale, APHP. Centre Université Paris Cité, Hôpital Cochin Port-Royal, Paris, France.

Laila El Khattabi (L)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.
Institut Cochin, INSERM U1016, team « From gametes to birth », Paris, France.

Thierry Bienvenu (T)

Service de Médecine Génomique des maladies de système et d'organe, APHP. Centre Université Paris Cité, Paris, France.

Classifications MeSH